Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent Read More Advocacy at a Glance STEVEN GROSSMAN 1/17/20 Advocacy at a Glance STEVEN GROSSMAN 1/17/20 The Lull Before FY 21 Appropriations, But Hardly Quiet in Washington Read More Analysis and Commentary STEVEN GROSSMAN 12/20/19 Analysis and Commentary STEVEN GROSSMAN 12/20/19 Success Again in 2019 ... Building Support for 2020 Read More Advocacy at a Glance STEVEN GROSSMAN 12/20/19 Advocacy at a Glance STEVEN GROSSMAN 12/20/19 FY 20 Appropriations: Headed to the President for His Signature Read More Analysis and Commentary STEVEN GROSSMAN 12/16/19 Analysis and Commentary STEVEN GROSSMAN 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More Advocacy at a Glance STEVEN GROSSMAN 12/16/19 Advocacy at a Glance STEVEN GROSSMAN 12/16/19 Agreement in Principle on All 12 Appropriations Bills. House Slated to Vote Tuesday Read More Analysis and Commentary STEVEN GROSSMAN 12/8/19 Analysis and Commentary STEVEN GROSSMAN 12/8/19 Three Key Questions ... and the Answers Read More Advocacy at a Glance STEVEN GROSSMAN 12/8/19 Advocacy at a Glance STEVEN GROSSMAN 12/8/19 The 302(b) Allocations Deal: Fixes Some, But Not All, of the Problems Read More Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Continuing Resolution Extends Funding through December 20 Read More Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More Analysis and Commentary STEVEN GROSSMAN 10/25/19 Analysis and Commentary STEVEN GROSSMAN 10/25/19 Establishing Order: The Chickens and the Eggs Read More Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Final Senate Action on “Domestic” Minibus (Including Ag/FDA) Set for Next Week Read More Analysis and Commentary STEVEN GROSSMAN 10/5/19 Analysis and Commentary STEVEN GROSSMAN 10/5/19 Full-Year CR: Better Than a Shutdown, But ... Read More Advocacy at a Glance STEVEN GROSSMAN 10/5/19 Advocacy at a Glance STEVEN GROSSMAN 10/5/19 FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR Read More Analysis and Commentary STEVEN GROSSMAN 9/30/19 Analysis and Commentary STEVEN GROSSMAN 9/30/19 "Wouldn't It Be Wonderful" Read More Advocacy at a Glance STEVEN GROSSMAN 9/30/19 Advocacy at a Glance STEVEN GROSSMAN 9/30/19 President to Sign CR; Government Will Stay Open to November 21 Read More Older Posts
Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Advocacy at a Glance STEVEN GROSSMAN 5/1/20 Senate Returns May 4; Appropriations Activities Planned and Rules for Remote Voting Are Prominent Read More
Advocacy at a Glance STEVEN GROSSMAN 1/17/20 Advocacy at a Glance STEVEN GROSSMAN 1/17/20 The Lull Before FY 21 Appropriations, But Hardly Quiet in Washington Read More
Analysis and Commentary STEVEN GROSSMAN 12/20/19 Analysis and Commentary STEVEN GROSSMAN 12/20/19 Success Again in 2019 ... Building Support for 2020 Read More
Advocacy at a Glance STEVEN GROSSMAN 12/20/19 Advocacy at a Glance STEVEN GROSSMAN 12/20/19 FY 20 Appropriations: Headed to the President for His Signature Read More
Analysis and Commentary STEVEN GROSSMAN 12/16/19 Analysis and Commentary STEVEN GROSSMAN 12/16/19 FDA's "Appropriation Fate" Is Evaluated on a Daily Basis Read More
Advocacy at a Glance STEVEN GROSSMAN 12/16/19 Advocacy at a Glance STEVEN GROSSMAN 12/16/19 Agreement in Principle on All 12 Appropriations Bills. House Slated to Vote Tuesday Read More
Analysis and Commentary STEVEN GROSSMAN 12/8/19 Analysis and Commentary STEVEN GROSSMAN 12/8/19 Three Key Questions ... and the Answers Read More
Advocacy at a Glance STEVEN GROSSMAN 12/8/19 Advocacy at a Glance STEVEN GROSSMAN 12/8/19 The 302(b) Allocations Deal: Fixes Some, But Not All, of the Problems Read More
Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Advocacy at a Glance STEVEN GROSSMAN 11/22/19 Continuing Resolution Extends Funding through December 20 Read More
Analysis and Commentary STEVEN GROSSMAN 11/15/19 Analysis and Commentary STEVEN GROSSMAN 11/15/19 FY 20 Appropriations: More Qs; More As Read More
Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Advocacy at a Glance STEVEN GROSSMAN 11/15/19 Congressional negotiations continue on FY 20 funding, with the possibility that a deal is close Read More
Analysis and Commentary STEVEN GROSSMAN 11/11/19 Analysis and Commentary STEVEN GROSSMAN 11/11/19 FY 20 Appropriations: How, When, and Why? Read More
Advocacy at a Glance STEVEN GROSSMAN 11/11/19 Advocacy at a Glance STEVEN GROSSMAN 11/11/19 A November 21 shutdown now seems unlikely, but Congress will still need to pass a new CR that extends into December Read More
Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Advocacy at a Glance STEVEN GROSSMAN 11/1/19 Senate Passes First Minibus, Which Includes Ag/FDA Funding Read More
Analysis and Commentary STEVEN GROSSMAN 10/25/19 Analysis and Commentary STEVEN GROSSMAN 10/25/19 Establishing Order: The Chickens and the Eggs Read More
Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Advocacy at a Glance STEVEN GROSSMAN 10/25/19 Final Senate Action on “Domestic” Minibus (Including Ag/FDA) Set for Next Week Read More
Analysis and Commentary STEVEN GROSSMAN 10/5/19 Analysis and Commentary STEVEN GROSSMAN 10/5/19 Full-Year CR: Better Than a Shutdown, But ... Read More
Advocacy at a Glance STEVEN GROSSMAN 10/5/19 Advocacy at a Glance STEVEN GROSSMAN 10/5/19 FY 20 Starts Peacefully; No Shutdown, But Restrictions Under a CR Read More
Analysis and Commentary STEVEN GROSSMAN 9/30/19 Analysis and Commentary STEVEN GROSSMAN 9/30/19 "Wouldn't It Be Wonderful" Read More
Advocacy at a Glance STEVEN GROSSMAN 9/30/19 Advocacy at a Glance STEVEN GROSSMAN 9/30/19 President to Sign CR; Government Will Stay Open to November 21 Read More
